Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon Cancer Liver Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01856322
What this trial is testing

Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer

Who this might be right for
Colorectal CancerLiver MetastasisColorectal Adenocarcinoma
National Cancer Institute (NCI) 3
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Large-scale testing (Phase 3)Ended earlyNCT00394992
What this trial is testing

Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer

Who this might be right for
Colorectal CancerLiver Metastases
Dutch Colorectal Cancer Group 79
Not applicableLooking for participantsNCT06024837
What this trial is testing

Performance of Spectral CT-scan in Patients With Metastatic Colorectal Cancer: a Prospective Multicentre Study

Who this might be right for
Colo-rectal Cancer
Centre Hospitalier Universitaire de Saint Etienne 100
Not applicableNot Yet RecruitingNCT06504901
What this trial is testing

Evaluation of Efficacy and Safety of PD-1 Monoclonal Antibody in Combination With rhG-CSF, IL-2, and CapeOX in Initially Resectable Synchronous Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University 30
Testing effectiveness (Phase 2)UnknownNCT06120127
What this trial is testing

Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence

Who this might be right for
RadiotherapyImmunotherapyLiver Metastases+1 more
Fudan University 80
Not applicableUnknownNCT03551470
What this trial is testing

Minimally Invasive Simultaneous Colorectal and Liver Surgery

Who this might be right for
Colorectal Cancer
Azienda Ospedaliera San Giovanni Battista 22
Testing effectiveness (Phase 2)Study completedNCT01022541
What this trial is testing

Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Royal Marsden NHS Foundation Trust 47
Not applicableUnknownNCT01516710
What this trial is testing

Oslo Randomized Laparoscopic Versus Open Liver Resection for Colorectal Metastases Study

Who this might be right for
Secondary Malignant Neoplasm of LiverColorectal Neoplasms
Oslo University Hospital 280
Not applicableEnded earlyNCT01867918
What this trial is testing

LOTCOL Study: Local Treatment of Colo-rectal Liver Met

Who this might be right for
Metastatic Colo-rectal Cancer
Oslo University Hospital 3
Not applicableNot Yet RecruitingNCT05354674
What this trial is testing

Multimodal Deep Learning Signature for Evaluation of Response to Bevacizumab in Patient With Colorectal Cancer Liver Metastasis

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 302
Early research (Phase 1)Study completedNCT00972036
What this trial is testing

Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy

Who this might be right for
Colon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT03477019
What this trial is testing

Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsBreast Neoplasms
St. Olavs Hospital 17
Testing effectiveness (Phase 2)Study completedNCT02086656
What this trial is testing

PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES

Who this might be right for
Colorectal Cancer Liver Metastases
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 46
Early research (Phase 1)WithdrawnNCT00005030
What this trial is testing

SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
M.D. Anderson Cancer Center
Early research (Phase 1)UnknownNCT06545630
What this trial is testing

Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases

Who this might be right for
CarcinomaColorectal Cancer
West China Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00200200
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer

Who this might be right for
Hepatic MetastasesColon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 73
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Early research (Phase 1)UnknownNCT02882659
What this trial is testing

Dendritic Killer Cell-based Immunotherapy for Solid Tumors

Who this might be right for
Colorectal NeoplasmsHepatocellular CarcinomaNeoplasm Metastasis
FullHope Biomedical Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT03493061
What this trial is testing

Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM

Who this might be right for
Colo-rectal CancerLiver Metastases
Sun Yat-sen University 60
Next Page